Statistical analysis suggested that a high expression level of MTERF1 protein in CRC patients was strongly correlated with four clinicopathological parameters of CRC, namely, patient lymph node status (p = 0.0044, χ2 = 8.1251), tumor stage (p = 0.0019, χ2 = 9.6651), nodal stage (p = 0.0044, χ2 = 8.1251), and clinical stage (p = 0.0044, χ2 = 8.1251) (Table S1). The gene discussed is MTERF1; the disease is neoplasm.